The restructuring will primarily affect the company’s research and administrative functions. As a result of the restructuring, most research programs will be placed on hold. The company may seek to partner these assets with companies looking for early-stage programs.
Helen Kim, Kosan’s CEO, said: “This represents an important step in Kosan’s evolution to a product-oriented company. We believe that this restructuring will strengthen our ability to effectively manage our resources, execute on our development goals and advance our high-value, near-term commercial opportunities.”